Impact of China’s zero mark-up drug policy on drug cost of NCDs’ outpatients: an interrupted time series analysis

BACKGROUND: China proposed the Zero Markup Drug Policy (ZMDP), which popularized in tertiary hospitals across the country in 2017, to control drug expenditures’ rapid growth further and reduce the public’s medical burden. This study aims to evaluate the impact of ZMDP on the drug cost of chronic dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Jielin, Xie, Jiajia, Qian, Yan, Wu, Mingyue, Huang, Wenjing, Yin, Jin, Peng, Xin, Deng, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086109/
https://www.ncbi.nlm.nih.gov/pubmed/33926444
http://dx.doi.org/10.1186/s12913-021-06414-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086109/
https://www.ncbi.nlm.nih.gov/pubmed/33926444
http://dx.doi.org/10.1186/s12913-021-06414-3

Ejemplares similares